When all else fails..read the directions
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MultiCell Technologies, Inc. filed its 10Q quarterly report with the SEC Monday April 15th.
Got to love this stock, every other stock is sell, sell, sell..not qoil
Buy and hold.
http://www.barchart.com/opinions/stocks/QOIL
I don't see any time in Nov that it even got close
30/11/12 0.0001 0.0001 0.0001 0.0001 13,005,400 0.00 0.00% 0.0001 1.3 k 15
29/11/12 0.0001 0.0001 0.0001 0.0001 13,059,999 0.00 0.00% 0.0001 1.31 k 17
27/11/12 0.0001 0.0001 0.0001 0.0001 1,320,700 0.00 0.00% 0.0001 132 6
26/11/12 0.0001 0.0001 0.0001 0.0001 4,742,000 0.00 0.00% 0.0001 469 5
23/11/12 0.0001 0.0001 0.0001 0.0001 520,000 0.00 0.00% 0.0001 52 1
19/11/12 0.0001 0.0001 0.0001 0.0001 1,441,200 0.00 0.00% 0.0001 144 5
15/11/12 0.0001 0.0001 0.0001 0.0001 3,199,999 0.00 0.00% 0.0001 319 3
09/11/12 N/A N/A N/A 0.0001 546,000 0.00 0.00% 0.0001 54 2
08/11/12 0.0001 0.0001 0.0001 0.0001 1,000,100 0.00 0.00% 0.0001 100 2
07/11/12 0.0001 0.0001 0.0001 0.0001 2,579,999 0.00 0.00% 0.0001 257 3
05/11/12 0.0001 0.0001 0.0001 0.0001 250,760 0.00 0.00% 0.0001 25 2
02/11/12 0.0001 0.0001 0.0001 0.0001 2,718,731 0.00 0.00% 0.0001 271 6
01/11/12 0.0001 0.0001 0.0001 0.0001 2,562,000 0.00 0.00% 0.0001 256 7
Actually, I think this is one of the few penny stocks that I have seen that don't have a bunch of mess going on. I just don't think this is a rinse and repeat.
Trust me I understand. Things in life are either one or the other, rarely are they "truly unknown" and I think this one here has the quality of an unknown. We shall see.
I know exactly what your saying, but something is not measuring up when you add the volume over the last few months, someone is buying and someone is buying big, no two ways about it.
A friend the other day called this stock the chance of a lifetime and a millionaire maker. I think he is right on the mark.
I guess there is something for everyone ;)
Hey there,
I'm not mad, I was just stating fact. My economics instructor taught us that you have to be a little company, before you an be a big company. The process that this company is going through is very competitive and a real pain in the rear. It may take them several more months or even a year (I seriously doubt a year, but it could) Regulations, although they have relaxed in the last several years are still a mess of red tape and BS. This is a long haul stock, I see people flipping it, but if you want to make real money, it's a long haul. I teach Health Information Technology and trust me when I say that the Medical Industry is about the slowest moving industry that I have ever seen when it comes to development. I guess that being said, since they are dealing with people lives, that's a good thing.
Respectfully yours,
Colleen
and I quote "Talked to a professional trader today and he told me BMSN has too many shares outstanding and he would never invest in a company that has over 100 mil shares"
Little confused by a professional making that statement, because it seems one of the richest men around purchased 100 million shares of dell two days ago.
http://www.fool.com/investing/general/2013/03/06/cnbc-icahn-buys-100-million-shares-of-dell.aspx
I have nothing but time and a whole bunch of share.. I'm not going anywhere.
I believe you are 100% correct.
So funny, I do not have this feeling about any other of the stock I have ever purchased, cannot get rid of the feeling that it's going to go nuts. Maury call's it women's intuition, I laugh when he went and purchased some, he said he has learned to never mess with a woman's intuition, lol.
LOL, want to go shopping? ;)
Wow, let me speak more slowly for you. What I put out there was called a fact (that is a Noun and A thing that is indisputably the case) that is why I posed the question "why is it still trading", which goes against the logic of the PPS. So when you go to belittle someone, it only shows that you do not understand the question. Thankfully, someone else did and responded with an answer.
Like your own little stream of gold, lol. Good for you.
What I find curious is that over a 30 day period 879,206,479 changed hands and the daily average is 82,103,968. Makes me wonder who is buying what and why? pump and dumb, share buy back, something about to break, insider trading... Just seems strange to me that a company is in "apparent" financial straights, yet has that kind of volume. People are not stupid, they are not going to just throw money away. IMO
4/4/2013 7,709,061
3/4/2013 34,968,999
2/4/2013 41,318,101
1/4/2013 22,424,524
28/03/13 48,980,173
27/03/13 3,217,489
26/03/13 9,223,803
25/03/13 29,887,332
22/03/13 9,743,294
21/03/13 27,438,516
20/03/13 29,747,328
19/03/13 26,422,072
18/03/13 62,663,826
15/03/13 49,693,141
14/03/13 32,401,255
13/03/13 21,669,464
12/3/2013 18,869,267
11/3/2013 65,968,173
8/3/2013 168,169,915
7/3/2013 35,164,610
6/3/2013 48,335,157
5/3/2013 85,190,979
Daily avg 39,963,931
total 879,206,479
So you would throw down $8,700.00 just to dump your money? Seems to me someone who is an investor would have more sense than to throw down $8,700.00 on something with no hope at all, right? or is someone buying back shares? Just curious.
over 30 days avg is 4.5 million per trading day
total traded for 30 days 85,103,968
Just seems to me that if it was a dead stock, it would not be trading at all. IMO
Someone is buying a lot of shares, have you been watching? 87 million shares in 30 days, someone is buying. My gut says hold, so I'm going to go with my gut on this one.
No problem
Found what is in red below for you, this was as of the 26th of Mar, hope it helps. You can also call Pacific Stock and get an update.
Contact Info
4045 South Spencer Street
Suite 403
Las Vegas, NV 89119
Tel: (702) 361-3033
Fax: (702) 433-1979
info@pacificstocktransfer.com
I asked Pacific Stock Transfer (QOIL's agent) how many shares were out there....
Authorized: 14,998,000,000
Issued and Outstanding: 14,980,226,525
Restricted: 5,209,469,068
I agree, hold..maybe a long term, but some really good things take time.
Then perhaps selling is your only option
Well if you change your mind...I will see you on the floor
You sell, I'll buy... are you game?
Like I said..you sell..I'll buy, are you game?
speculation is so much fun...you sell..I buy.. It's all good and I am making a fine living on this side. Please feel free to dump your share on to the market..
Sell, I am waiting to buy your shares.
You are very wise.
Perhaps now is a good time for you to move on. I choose to hold, I think they are a winner.
Realize that technology is not a fast moving process..sit tight
MultiCell Patent Portfolio
Products
Patent Portfolio of MultiCell Technologies, Inc., MultiCell Immunotherapeutics and majority-owned subsidiary, Xenogenics. Patents already published which can be found in the public domain.
MultiCell Technologies, Inc.
US Patent 6,737,057: Compounds, compositions and methods for the Endocytic presentation of immunosuppressive factors
US Patent 6,129,911: Liver stem cell
US Patent 6,872,389: Liver stem cell
US Patent 6,017,760: Isolation and culture of porcine hepatocytes
US Patent 6,107,043: Immortalized hepatocytes
US Patent 5,043,260: Perfusion device with hepatocytes
US Patent 4,795,459: Implantable Prosthetic Device (endothelial)
US Patent 6,858,146: Artificial Liver Apparatus and Method (Trademarked as the SybiolR synthetic bio-liver)
US Patent 7,935,528 The invention provides a primary liver stem cell and a cell doublet consisting of a hepatocyte and the stem cell, both of which are derived from normal liver tissue. Methods of isolating the cells, genetically altering the cells, and using the cells for transplantation are also within the invention.
US Patent 7,566,567: Immortalized hepatocytes
US20070104696A1: Use of cell lines to produce active therapeutic proteins
US20070004039A1: Immortalized hepatocytes
EP1704227B1:
IMMORTALIZED HEPATOCYTES
DE602004025380C0: IMMORTALISIERTE HEPATOZYTEN
AT0456376E: IMMORTALISIERTE HEPATOZYTEN
AU8229981A1: Immortalized hepatocytes
AU4322811AH: Immortalized hepatocytes
EP1704227A4: IMMORTALIZED HEPATOCYTES
WO06041488C1: IMMORTALIZED HEPATOCYTES
WO06041488A1: IMMORTALIZED HEPATOCYTES
IL0174787A0: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1685252A4: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1704227A1: IMMORTALIZED HEPATOCYTES
EP1685252A2: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2550452A1 IMMORTALIZED HEPATOCYTES
AU4322811A1 Immortalized hepatocytes
WO05034876A3 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
WO05034876A2 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2541380A1 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
AU4280238AB Use of cell lines to produce active therapeutic proteins
AU4280238A1 Use of cell lines to produce active therapeutic proteins
Xenogenics.
When Xenogenics acquired the assets of Bioabsorbable Therapeutics, Inc., it acquired and continues to support issued U.S. patent 7,674,285: Polyanhydride polymers and their uses in biomedical devices. This process is incorporated in and trademarked as the Ideal Bio-StentR.
MultiCell ImmunoTherapeutics.
Below is a listing of the intellectual properties of which Astral, Inc. is the Assignee. This intellectual property is now owned by MultiCell Immunotherapeutics resulting from the purchase agreement between MultiCell Technologies, Inc. and Alliance Pharmaceuticals, Inc.
US20120189645A1:COMPOSITIONS AND METHODS TO TREAT AND CONTROL TUMORS.
CN100376594C: DOUBLE-CHAIN RNA AND METHOD TO INITIATE, ENHANCE OR ADJUST IMMUNOMODULATORY OR IMMUNE RESPONSE.
CN1795274A: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
CN1780848A: COMPOSITIONS AND METHODS TO INITIATE OR ENHANCE ANTIBODY AND
MAJOR-HISTOCOMPATIBILITY CLASS I OR CLASS II-RESTRICTED T CELL RESPONSES BY
USING IMMUNOMODULATORY, NON-CODING RNA MOTIFS.
WO04087877A3: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
CN1703427A: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS .
WO04087877A2: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
WO04027049B1: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO04027049A3: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO03078595B1: IMMUNOSTIMULATORY DOUBLE STRANDED RNA AND METHODS OF INDUCING, ENHANCING OR MODULATING THE IMMUNE RESPONSE.
WO04027049A2: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO03078595A3: IMMUNOSTIMULATORY DOUBLE STRANDED RNA AND METHODS OF INDUCING, ENHANCING OR MODULATING THE IMMUNE RESPONSE.
CA2520181A1: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
CA2499066A1: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
AU4225480A1: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
AU3276932A1: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO03078595A2: COMPOSITIONS AND METHODS TO INITIATE OR ENHANCE ANTIBODY AND MAJOR-HISTOCOMPATIBILITY CLASS I OR CLASS II-RESTRICTED T CELL RESPONSES BY
USING IMMUNOMODULATORY, NON-CODING RNA MOTIFS.
CA2479187A1: IMMUNOSTIMULATORY DOUBLE STRANDED RNA AND METHODS OF INDUCING, ENHANCING OR MODULATING THE IMMUNE RESPONSE.
AU3218181A1: COMPOSITIONS AND METHODS TO INITIATE OR ENHANCE ANTIBODY AND MAJOR-HISTOCOMPATIBILITY CLASS I OR CLASS II-RESTRICTED T CELL RESPONSES BY USING IMMUNOMODULATORY, NON-CODING RNA MOTIFS.
US7566567: Immortalized hepatocytes
US20070104696A1: Use of cell lines to produce active therapeutic proteins
US20070004039A1: Immortalized hepatocytes
EP1704227B1:
IMMORTALIZED HEPATOCYTES
DE602004025380C0: IMMORTALISIERTE HEPATOZYTEN
AT0456376E: IMMORTALISIERTE HEPATOZYTEN
AU8229981A1: Immortalized hepatocytes
AU4322811AH: Immortalized hepatocytes
EP1704227A4: IMMORTALIZED HEPATOCYTES
WO06041488C1: IMMORTALIZED HEPATOCYTES
WO06041488A1: IMMORTALIZED HEPATOCYTES
IL0174787A0: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1685252A4: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1704227A1: IMMORTALIZED HEPATOCYTES
EP1685252A2: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2550452A1 IMMORTALIZED HEPATOCYTES
AU4322811A1 Immortalized hepatocytes
WO05034876A3 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
WO05034876A2 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2541380A1 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
AU4280238AB Use of cell lines to produce active therapeutic proteins
AU4280238A1 Use of cell lines to produce active therapeutic proteins
really, 15 million in one buy.. someone is buy this stuff up really quickly.
16.5 million shares by 12PM, someone like it ... lol
Did I say it did? no, I just commented on it.
42 minutes into trading and 1.6 million?
I have a feeling this is going to be a very good year.